|1.||Njeh, Akram: 1 article (01/2015)|
|2.||Uzunoglu, Emel: 1 article (01/2015)|
|3.||Goldberg, Michel: 1 article (01/2015)|
|4.||Duncan, H F: 1 article (02/2008)|
|5.||Pitt Ford, T R: 1 article (02/2008)|
|6.||Luder, H U: 1 article (02/2008)|
|7.||Nair, P N R: 1 article (02/2008)|
01/01/2015 - "Due to the high alkalinity of the capping agent, pulp cells display mild inflammation, proliferate, and increase in number and size and initiate mineralization. "
02/01/2008 - "The MTA was clinically easier to use as a direct pulp-capping agent and resulted in less pulpal inflammation and more predictable hard tissue barrier formation than Dycal. "
|2.||Bone Diseases (Bone Disease)